Mandate

Vinge advises Industrifonden in connection with its investment in solar cells company, Sol Voltaics

July 04, 2011

Vinge has advised Stiftelsen Industrifonden in connection with its SEK 18.5 million investment in the solar cells company, Sol Voltaics. Sol Voltaics has developed a completely new type of material which can significant reduce the cost of producing electricity from solar cells. The total amount of the issue is SEK 40 million and the capital will be used for the future development of the company’s products. Sol Voltaics has developed a new material and a new production method for the manufacture of solar cells. In brief, it is based upon the rapid production of nano threads of gallium arsenide (GaAs), where each thread is a solar cell. This material has been widely recoginsed for some time as the best way of manufacturing solar cells although up to now it has been too expensive to use. Sol Volatics has now developed a method which can radically reduce the costs associated with the aforementioned method.

Vinge’s team consisted of Johan Larsson (project manager) and Claes Henriksson. Johan Winnerblad was the responsible partner.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026